Jolanta Mazurek

Markus Sköld2
Chaniya Leepiyasakulchai2
2Markus Sköld
2Chaniya Leepiyasakulchai
2Gunilla Källenius
Learn More
  • Linus Sandegren, Ramona Groenheit, Tuija Koivula, Solomon Ghebremichael, Abdolreza Advani, Elsie Castro +8 others
  • 2011
In molecular epidemiological studies of drug resistant Mycobacterium tuberculosis (TB) in Sweden a large outbreak of an isoniazid resistant strain was identified, involving 115 patients, mainly from the Horn of Africa. During the outbreak period, the genomic pattern of the outbreak strain has stayed virtually unchanged with regard to drug resistance, IS6110(More)
BACKGROUND Mycobacterium tuberculosis (Mtb) is able to evade the immune defenses and may persist for years, decades and even lifelong in the infected host. Mtb cell wall components may contribute to such persistence by modulating several pivotal types of immune cells. Dendritic cells (DCs) are the most potent antigen-presenting cells and hence play a(More)
  • Chaniya Leepiyasakulchai, Chato Taher, Olga D. Chuquimia, Jolanta Mazurek, Cecilia Söderberg-Naucler, Carmen Fernández +1 other
  • 2013
Non-hematopoietic cells, including lung epithelial cells, influence host immune responses. By co-culturing primary alveolar epithelial cells and monocytes from naïve donor mice, we show that alveolar epithelial cells support monocyte survival and differentiation in vitro, suggesting a role for non-hematopoietic cells in monocyte differentiation during the(More)
  • Lech Ignatowicz, Jolanta Mazurek, Chaniya Leepiyasakulchai, Markus Sköld, Jorma Hinkula, Gunilla Källenius +1 other
  • 2012
Tuberculosis (TB) has emerged as the most prominent bacterial disease found in human immunodeficiency virus (HIV)-positive individuals worldwide. Due to high prevalence of asymptomatic Mycobacterium tuberculosis (Mtb) infections, the future HIV vaccine in areas highly endemic for TB will often be administrated to individuals with an ongoing Mtb infection.(More)
  • 1